Axi-cel met primary endpoint in phase III trial of DLBCL in first relapse vs salvage chemo and Auto. at median f/u of 2 years EFS; hazard ratio 0.398, p <0.0001. No OS benefit yet, but not yet mature.
This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript…
Cigarette butts are the most littered item on the planet. Two new studies from the Institute for Global Tobacco Control point to possible solutions.
This year’s Congress of Clinical Rheumatology-East will celebrate the annual meeting’s 40th anniversary with banquets, record in-person attendance and a host of new presenters. “Forty…
Researchers in Charleston, South Carolina, are trying to build a DNA database of 100,000 people to better understand how genetics affects health risks. But they’re…
Increasing screening for younger individuals who are at risk of colorectal cancer may help mitigate the rising early incidence of this disease.
El programa ofrecerá una excelente oportunidad para compartir los últimos avances en diagnóstico y tratamiento integral de la epilepsia desde aspectos sociales, farmacología, terapias alternativas,…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
This Medical News article discusses how aggregated data obscure large health disparities among the 24 million Asian American people in the US.
At AACN’s premier conference for progressive and critical care nurses, attend NTI your way. Join us for the unparalleled education and energy you expect from…
An official journal of the Gerontological Society of America. Provides a multidisciplinary perspective on human aging through the publication of research and analysis in gerontology,…
